A merger between the two companies was completed Jan. 5, 2023, according to a Nov. 7 press release.
The lawsuit, filed on behalf of former SeaSpine Holdings Corporation shareholders that purchased or otherwise acquired newly issued Orthofix Medical stock in exchange for SeaSpine, claims that at the time of the merger, defendants failed to disclose that Orthofix lacked adequate internal controls.
The complaint also alleges that Orthofix leadership had deficient compliance and training programs, which resulted in “lax vetting of incoming executive hires; senior management and directors engaging in rampant harassment and other inappropriate misconduct in violation of the company’s purported ethical and professional standards; prioritization of personal and financial incentives over ensuring that Orthofix and its management complied with applicable laws, regulations, and contracts,” according to the release.
It also alleges that Orthofix’s SEC filings and public disclosures had material misstatements.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
